The Science Behind Our Products

Our Research-Backed Formulations

At 199 Longevity, we develop products based on cutting-edge research in longevity science. Each of our formulations targets specific biological pathways associated with aging, with the goal of supporting healthier, more vibrant lives.

Explore the science behind our products below. We believe in transparency about our ingredients and their mechanisms of action, so you can make informed decisions about your health.

Procyanidin C1 Senolytic Complex (PCC1™)

Procyanidins are a class of polyphenol compounds composed of flavan-3-ol subunits (such as catechins and epicatechins) linked together. They are abundant in many plant-based foods including grape seeds, apples, cinnamon, and cocoa, making them natural components of the human diet for thousands of years.

Procyanidin C1 (PCC1) is a specific type of trimeric procyanidin with remarkable health properties. Research published in Nature Metabolism (2021) demonstrated that PCC1 has potent effects on cellular aging through two key mechanisms: senolytic and senomorphic activity.

Understanding Senolytic & Senomorphic Activity

Senolytic

Senolytics are compounds that can selectively eliminate senescent cells (aging "zombie" cells) through programmed cell death while sparing healthy cells. This helps remove harmful cells that secrete inflammatory compounds.

Senomorphic

Senomorphics don't kill senescent cells but instead modify their behavior to reduce the harmful inflammatory signals they produce (the Senescence-Associated Secretory Phenotype or SASP), decreasing their negative impact on surrounding tissues.

Mechanism of Action

PCC1 works through several biological pathways to support cellular health:

  • Selective Elimination of Senescent Cells: PCC1 can induce apoptosis (programmed cell death) in senescent cells while sparing healthy cells.
  • Inhibition of PI3K/AKT Pathway: Research suggests PCC1 blocks this key survival pathway in senescent cells, which is more potent than the commonly studied senolytic combination of dasatinib and quercetin (D+Q).
  • Reduction of SASP: PCC1 significantly reduces the secretion of inflammatory compounds by senescent cells, including interleukins IL-6, IL-8, and TGF-β, which are major drivers of chronic inflammation.
  • Antioxidant Activity: As a polyphenol, PCC1 also exhibits antioxidant properties that can help combat oxidative stress.

Human-Relevant Research

Unlike many experimental compounds, procyanidins have a long history of human consumption and safety. Research has demonstrated several concrete benefits of PCC1:

  • Improved physical function in aged animal models
  • Enhanced cardiovascular parameters
  • Reduced biomarkers of inflammation (IL-6, IL-8, TNF-α)
  • Improved cellular stress resistance
  • Extended lifespan in animal models by approximately 9-11%

The 2021 Nature Metabolism study showed that PCC1 was more effective than other senolytics in some contexts. Animals treated with PCC1 demonstrated significantly improved physical function and increased median lifespan. Most remarkably, when looking at mice that were already 24 months old (equivalent to a ~70-year-old human), their remaining lifespan was extended by over 60% compared to controls.

Lifespan Extension Data

Lifespan curve showing PCC1 vs control group

Fig 1a: Survival curves of aged mice (24-27 months old) treated with PCC1 or vehicle control. The blue line represents PCC1-treated mice and shows significantly improved survival compared to controls (black line).

Mortality hazard graph for PCC1 treatment

Fig 1b: Mortality hazard analysis showing 65% reduction in mortality risk with biweekly PCC1 administration compared to the control group.

Key Finding: Mice receiving PCC1 administration (once every two weeks or biweekly) starting at 24–27 months of age (roughly equivalent to an age of 75–90 years in humans) had a 64.2% longer median post-treatment lifespan (or 9.4% longer overall lifespan) and lower mortality hazard (65.0%, P < 0.0001) than the vehicle-treated group, as shown in the figures above.

Key Research on Procyanidin C1

Here are the most significant studies on Procyanidin C1 (PCC1) demonstrating its effects on lifespan, senescence, and age-related diseases:

Xu et al., 2021

The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice

Xu, Q., Fu, Q., Li, Z., Liu, H., Wang, Y., Lin, X., … & Xu, H. (2021). The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nature Metabolism, 3(12), 1706–1726.

DOI: 10.1038/s42255-021-00491-8

Summary: The landmark study published in Nature Metabolism that first demonstrated PCC1's ability to extend lifespan in mice by approximately 9.4% overall, with a 64.2% longer post-treatment lifespan when started in aged mice. The paper established PCC1's mechanism as both senolytic and senomorphic.

Liu et al., 2024

Senolytic flavonoid procyanidin C1 rejuvenates retinal function in aging mice

Liu, Y., Wu, H., Nie, Q., Zhang, X., Yu, L., Wang, Y., … & Jiang, C. (2024). Senolytic flavonoid procyanidin C1 rejuvenates retinal function in aging mice. Proceedings of the National Academy of Sciences (PNAS), 121(8), e2312270121.

DOI: 10.1073/pnas.2312270121

Summary: This recent study from PNAS demonstrates that PCC1 can rejuvenate retinal function in aging mice by targeting senescent cells in the retina, showing potential benefits for age-related vision decline.

Shao et al., 2024

Procyanidin C1 attenuates pulmonary fibrosis by selectively eliminating senescent cells

Shao, H., Zhang, R., Yan, J., Zhang, J., Wang, X., Qin, Y., … & Liu, Z. (2024). Procyanidin C1 attenuates pulmonary fibrosis by selectively eliminating senescent cells. The FASEB Journal, 38(3), e23080.

DOI: 10.1096/fj.202302043R

Summary: Research published in The FASEB Journal showing that PCC1's senolytic properties can reduce pulmonary fibrosis by eliminating senescent cells in lung tissue, suggesting potential therapeutic applications for certain respiratory conditions.

Park et al., 2014

Vascular endothelial function is influenced by procyanidin trimer C1 from grape seeds

Park, E., Edirisinghe, I., Wei, H., Vijayakumar, L. P., & Burton-Freeman, B. (2014). Vascular endothelial function is influenced by procyanidin trimer C1 from grape seeds. Journal of Medicinal Food, 17(11), 1176–1183.

DOI: 10.1089/jmf.2013.0179

Summary: Earlier research documenting PCC1's beneficial effects on vascular endothelial function, showing potential cardiovascular benefits beyond the senotherapeutic effects discovered later.

Bae et al., 2020

Procyanidin C1 inhibits melanoma cell growth via activation of the 67-kDa laminin receptor signaling pathway

Bae, J., Kumazoe, M., Yamashita, S., Tachibana, H. (2020). Procyanidin C1 inhibits melanoma cell growth via activation of the 67-kDa laminin receptor signaling pathway. Journal of Agricultural and Food Chemistry, 68(18), 5285–5292.

DOI: 10.1021/acs.jafc.0c00289

Summary: Research showing PCC1's potential anticancer properties through a specific cellular signaling pathway, indicating that its benefits may extend beyond direct senolytic effects to include other protective mechanisms.

Recent 2024 research has also demonstrated benefits for retinal aging by targeting senescent cells, showing PCC1's potential for supporting eye health during aging.

PCC1 Supplement

Key Benefits

  • Targets cellular senescence more effectively than D+Q
  • Reduces key inflammatory markers (IL-6, IL-8, TGF-β)
  • Demonstrated lifespan extension in research studies
  • Natural food-derived compound with established safety
  • Dual action: both senolytic and senomorphic properties

Shopping cart